CDK4 and central nervous system cancer: The identified target genes (Cdk4, Ccne2, Ccnd3, and Ccnd1) are core regulatory factors of the cell cycle that drive the transition from the quiescent phase (G1) to the DNA synthesis phase (S), and they are not only essential for neuroglial development but are also frequently dysregulated in gliomas.